Important information regarding cookies and imb.ie
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Avastin (bevacizumab) - Important Safety Information from Roche as approved by the Irish Medicines Board

04 May 2010

Important Safety Information communication from Roche on the association of bevacizumab, Avastin® with Hypersensitivity and Infusion reactions.

Important Safety Information - Avastin (bevacizumab)





Date Printed: 20 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971